ADHD

Gambling

Opioid Related Disorders

Alcohol Abuse

Amphetamine Related Disorders

Substance Use Disorder

Addiction & Substance Use

Disaster Psychiatry

Panic Disorder

PTSD

Trauma And Violence

Traumatic Stress Disorders

Anxiety & Stress Disorders

Mania

Bipolar Disorder

Bipolar I Disorder

COVID-19

Cannabis

Case Discussions

Comorbidity

Compulsive Disorders

Cultural Psychiatry

Dysthymia

Electroconvulsive Therapy

Major Depressive Disorder

Depression

Digital Psychiatry

Digital Therapeutics

Eating Disorders

Ethics

Munchausen Syndrome

Sexual Offenses

Forensic Psychiatry

Impulse Control Disorder

Integrative Psychiatry

International Overdose Awareness

Mental Health Systems

Mood Disorders

Cognitive Disorders

Dementia

Alzheimer Disease

Autism

Neuropsychiatry

Pain

Compulsive Personality Disorder

Dependent Personality Disorder

Dissociative Identity Disorder

Histrionic Personality Disorder

Schizoid Personality Disorder

Antisocial Personality Disorder

Borderline Personality

Personality Disorders

Psychedelics

Psychiatric Emergencies

Psychopharmacology

Delirium

Metabolic Disorders

Somatoform Disorder

Psychosomatics

Cognitive Behavioral Therapy

Psychotherapy

Paranoid Schizophrenia

Psychotic Affective Disorders

Schizoaffective

Schizophrenia Psychotic Features

Schizotypal Personality Disorder

Tardive Dyskinesia

Catatonic Schizophrenia

Schizophrenia/Psychosis

Masochism

Sexual Addiction

Sexual & Sexuality

Nocturnal Paroxysmal Dystonia

Sleep Deprivation

Sleep Wake Transition

Circadian Rhythm Sleep Disorders

Sleep Disorders

Pervasive Developmental Disorder

Diversity Reflections

Gender Issues

Geriatric Psychiatry

Military Mental Health

Child & Adolescent Psychiatry

Special Populations

Suicide

Transcranial Magnetic Stimulation

News

Media

Around the Practice

Between the Lines

PsychView

Expert Perspectives

Case-Based Psych Perspectives

Medical World News

Payer-Provider Perspective

Slideshows

Videos

Viewpoints

Webinars

Publications

Psychiatric Times

All Publications

Partner Perspectives

Job Board

CME/CE

Partners

Resources

Clinical Scales

Conference Coverage

Conference Listing

Interactive Tools

Quizzes

Series

Special Reports

Tipsheets

Toolkits

Subscribe

Print Subscription

eNewsletter

is a 4th-year medical student at Texas A&M School of Medicine applying to psychiatry residency. He has previously worked with refugee camps in Jordan to assist with psychiatric and medical care.

Articles

Look through the eyes of a medical health care team in a refugee camp with a focus on children’s mental health. 

From Crisis to Coping: Strategies for Supporting Trauma-Affected Refugee Youth

Get ready for our upcoming virtual, interactive conference with some highlights from 2022.

A Look Back at the 2022 Annual Psychiatric Times® World CME Conference

is an award-winning psychiatrist who specialized in the cultural and ethical aspects of psychiatry, and is now in retirement and refirement as a private pro bono community psychiatrist. A prolific writer and speaker, he has done a weekday column titled “Psychiatric Views on the Daily News” and a weekly video, “Psychiatry & Society,” since the COVID-19 pandemic emerged. He was chosen to receive the 2024 Abraham Halpern Humanitarian Award from the American Association for Social Psychiatry. Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. He is an advocate and activist for mental health issues related to climate instability, physician burnout, and xenophobia. He is now editing the final book in a 4-volume series on religions and psychiatry for Springer: Islamophobia, anti-Semitism, Christianity, and now

Avoiding hubris: connections between the unsinkable ship and psychiatry. 

We Interrupt This Series on Awe to Bring You News About the Titanic

Is psilocybin a viable treatment for MDD? Researchers performed a phase 2, double blind trial of single-dose psilocybin in patients with treatment resistant depression.

Single-Dose Psilocybin for Treatment-Resistant Major Depression

Advertise

Contact Us

Editorial

Terms and Conditions

Privacy Policy

Do Not Sell My Personal Information

Twitter

Facebook

LinkedIn

Spotlight

Expert Perspectives on the Clinical Management of Bipolar 1 Disorder

Expert Perspectives on the Unmet Needs in the Management of Major Depressive Disorder

Novel Delivery Systems Utilized in the Treatment of Adult ADHD

Commentary

Couch In Crisis

Early Career Psychiatry

History of Psychiatry

Residents Corner

Cultural Corner

Film and Book Reviews

Poetry

Writers Contest

Psychiatric Practice

Burnout

Careers

Coding

Guidelines

Risk Management

Telepsychiatry

Climate Change

Critical Conversations in Psychiatry

Portraits

Psychiatric Views on the Daily News

Tales From the Clinic: The Art of Psychiatry

Tales from the New Asylum

1rem

Authors

The Research Domain Criteria (RDoC) program: how it evolved, clinical applications, and goals.

The NIMH Research Domain Criteria (RDoC): New Concepts for Mental Disorders

Bruce N. Cuthbert, PhD

Articles